AlphaCentric Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$378K Buy
886
+85
+11% +$34.8K 0.34% 95
2026
Q2
$312K Buy
801
+37
+5% +$15.6K 0.26% 129
2026
Q1
$362K Buy
764
+496
+185% +$250K 0.36% 95
2025
Q4
$125K Buy
+268
New +$124K 0.12% 199
2024
Q4
$91.2K Sell
304
-17
-5% -$5.94K 0.09% 164
2024
Q3
$130K Sell
321
-12
-4% -$4.39K 0.1% 158
2024
Q2
$107K Sell
333
-321
-49% -$104K 0.08% 154
2024
Q1
$218K Buy
+654
New +$200K 0.13% 126
2023
Q4
– Sell
-390
Closed -$95.9K – 255
2023
Q3
$95.9K Sell
390
-41
-10% -$11.2K 0.05% 201
2023
Q2
$131K Buy
+431
New +$120K 0.07% 180
2021
Q4
$162K Sell
629
-117
-16% -$28.6K 0.05% 117
2021
Q3
$181K Hold
746
– – 0.05% 113
2021
Q2
$154K Buy
+746
New +$152K 0.04% 136

Other funds holding HCA

AlphaCentric Advisors's HCA Position: Q3 2026 in Review

AlphaCentric Advisors increased its HCA Healthcare (HCA) stake by 11% in Q3 2026, buying an estimated $34.8K and bringing the position to 886 shares worth $378K. The position accounts for 0.34% of the portfolio, ranked #95.

AlphaCentric Advisors first reported a position in HCA in Q2 2021 and has held it in 13 quarters since. 848 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • AlphaCentric Advisors held 886 shares of HCA Healthcare worth $378K as of Q3 2026.
  • AlphaCentric Advisors bought 85 HCA Healthcare shares in Q3 2026, an estimated $34.8K.
  • HCA Healthcare made up 0.34% of AlphaCentric Advisors's portfolio in Q3 2026, its #95 holding.
  • AlphaCentric Advisors first reported a position in HCA Healthcare in Q2 2021 and has held it in 13 quarters since.
  • 848 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.